help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rittmaster, R. S.
Right arrow Articles by Thompson, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rittmaster, R. S.
Right arrow Articles by Thompson, D. L.

Endocrinology, Vol 123, 2788-2792, Copyright © 1988 by Endocrine Society


ARTICLES

Preferential metabolism of dihydrotestosterone to androstanediol 17- glucuronide in rat prostate

RS Rittmaster, CA Leopold and DL Thompson
Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Androstanediol glucuronide (Adiol G), a marker of peripheral dihydrotestosterone (DHT) metabolism and action, may be conjugated through the hydroxyl group at either the 3-carbon (Adiol 3-G) or 17- carbon (Adiol 17-G) position. Adiol 17-G is the predominant Adiol G isomer derived from DHT in normal men. To determine whether peripheral tissues may be responsible for this selective conversion of DHT to Adiol 17-G, a glucuronyl transferase assay was developed using rat prostate cells. Adiol 17-G was separated from Adiol 3-G by HPLC and selective precipitation with an antibody specific for Adiol 3-G. Using androstanediol (Adiol) as a substrate, enzyme kinetics were linear with respect to time and enzyme concentration. In the presence of 0 or 5 microM Adiol and 1 microCi [3H]Adiol, greater than 99% of the resulting Adiol G was Adiol 17-G. The percent conversions of DHT, Adiol, and androsterone to their glucuronide conjugates were 0.22%, 3.5%, and 0.24%/10(6) prostate cells, respectively. Using DHT as an inhibitor of Adiol glucuronidation, the Ki was 39.1 microM, compared to an apparent Km for Adiol of 15 microM. We conclude that rat prostate cells can selectively convert Adiol to Adiol 17-G, and that Adiol glucuronidation is favored over that of DHT or androsterone under these experimental conditions. Since DHT and Adiol are readily interconvertable, these results suggest that Adiol 17-G is the major DHT metabolite in the rat prostate.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society